ArticleJournal of clinical medicine2026

Comparison of the Safety and Effectiveness of Apixaban Versus Rivaroxaban in Acute Venous Thromboembolism: A Propensity-Matched Real-World TriNetX Study with Obesity and Cancer Subgroup Analyses.

Faizan Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.